Recombinant Human EXOSC5/CML28 protein is a Human Full Length protein, in the 1 to 235 aa range, expressed in Escherichia coli, with >90% purity and suitable for SDS-PAGE, MS.
M G S S H H H H H H S S G L V P R G S H M M E E E T H T D A K I R A E N G T G S S P R G P G C S L R H F A C E Q N L L S R P D G S A S F L Q G D T S V L A G V Y G P A E V K V S K E I F N K A T L E V I L R P K I G L P G V A E K S R E R L I R N T C E A V V L G T L H P R T S I T V V L Q V V S D A G S L L A C C L N A A C M A L V D A G V P M R A L F C G V A C A L D S D G T L V L D P T S K Q E K E A R A V L T F A L D S V E R K L L M S S T K G L Y S D T E L Q Q C L A A A Q A A S Q H V F R F Y R E S L Q R R Y S K S
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application SDS-PAGE | Reactivity Reacts | Dilution info - | Notes - |
Application MS | Reactivity Reacts | Dilution info - | Notes - |
Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes (PubMed:11782436, PubMed:21269460). In vitro, EXOSC5 does not bind or digest single-stranded RNA and binds to double-stranded DNA without detectable DNase activity (PubMed:20660080).
CML28, RRP46, EXOSC5, Exosome complex component RRP46, Chronic myelogenous leukemia tumor antigen 28, Exosome component 5, Ribosomal RNA-processing protein 46, p12B
Recombinant Human EXOSC5/CML28 protein is a Human Full Length protein, in the 1 to 235 aa range, expressed in Escherichia coli, with >90% purity and suitable for SDS-PAGE, MS.
pH: 7.4
Constituents: 68% PBS, 30% Glycerol (glycerin, glycerine), 1.17% Sodium chloride, 0.03% (R*,R*)-1,4-Dimercaptobutan-2,3-diol
ab124595 is purified using conventional chromatography techniques.
Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes (PubMed:11782436, PubMed:21269460). In vitro, EXOSC5 does not bind or digest single-stranded RNA and binds to double-stranded DNA without detectable DNase activity (PubMed:20660080).
Belongs to the RNase PH family.
This product was previously labelled as EXOSC5
EXOSC5 also known as CML28 is a core component of the exosome complex an important multiprotein machinery involved in RNA processing and degradation. EXOSC5 has a molecular mass of approximately 34 kDa and is expressed in a wide range of tissues. It functions as a scaffold within the exosome complex interacting with other exosome subunits to maintain the stability and structure of the complex.
EXOSC5 is important for the normal function of the RNA exosome complex which plays a central role in 3'-to-5' RNA processing and degradation. The exosome complex is essential for removing defective RNA molecules and managing RNA stability. EXOSC5 acts as a bridge between the core exosome and additional cofactors that enhance the exosome's specific functions. This regulation ensures appropriate cellular RNA levels impacting gene expression and integrity.
EXOSC5 is involved in the RNA surveillance pathway which monitors and degrades aberrant RNA transcripts in the cell. The pathway ensures that only properly processed RNAs are translated into proteins. Within this framework EXOSC5 interacts with RRP44 a catalytic component of the exosome bolstering its activity in degrading faulty RNAs. The balance of RNA processing and degradation that EXOSC5 supports is vital in maintaining cellular homeostasis.
Abnormalities in EXOSC5 have been linked to autoimmune diseases and cancers. Autoimmune responses may target EXOSC5 leading to disrupted RNA processing. Moreover alterations in EXOSC5 expression or function can contribute to oncogenesis by impacting the cell cycle and apoptosis. In cancers interactions between EXOSC5 and the protein p53 suggest a connection in cell survival pathways highlighting EXOSC5's potential as a therapeutic target in cancer treatments.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
15% SDS-PAGE showing ab124595 (3μg).
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com